Summary
- Current Price
- As of today, DNTH price is $110.76, down -1.20% on
- Current Price All-Time High
- DNTH price is currently -6.04% below its historical high of $117.88 set on
- Market Cap
- DNTH current market cap is $6B, up +694.31% over the past 365 days
- Revenue
- DNTH current annual revenue is $2.04M, down -67.35% year-over-year
- Next Earnings
- The next earnings release for DNTH is on
Profile
| Metric | Value |
|---|---|
| Full Name | Dianthus Therapeutics, Inc. |
| Ticker | NASDAQ: DNTH |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | dianthustx.com |
| Employees | 78 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $110.76 | |
| Price, 1D Change | -1.20% | |
| $6B | ||
| - | ||
| - | ||
| 0.91 | ||
| $2.04M | ||
| Revenue, 1Y Change | -67.35% | |
| -$4.20 | ||
| EPS, 1Y Change | -64.81% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:16 | |
| Next Split | N/A | N/A |
| Last Ticker Change | MGTA | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$4.20 | ||
| EPS Estimate | -$3.92 | N/A |
| EPS Est. Change | +6.75% | N/A |
| $2.04M | ||
| Revenue Estimate | $1.81M | N/A |
| Revenue Est. Change | -10.92% | N/A |
| Current Price | $110.76 | |
| Price Target | $132.00 | - |
| Price Tgt. Change | +19.18% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.27 | -$2.55 | -12.36% | |
| -$3.65 | -$4.20 | -15.08% | |
| -$3.92 | N/A | +6.75% | |
| -$4.74 | N/A | -12.84% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.41M | $6.24M | +15.35% | |
| $2.27M | $2.04M | -10.12% | |
| $1.81M | N/A | -10.92% | |
| $1.72M | N/A | -15.70% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $110.76 | |
| $73.56 | ||
| $102.21 | ||
| $78.06 | ||
| $103.43 | ||
| $2.58 | ||
| 0.91 | ||
| $5.21 | ||
| 53.42 | ||
| 42.65% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $2.04M | ||
| -$4.20 | ||
| $1.61M | ||
| 78.98% | ||
| -$177.93M | ||
| -8,739.34% | ||
| -$162.34M | ||
| -7,973.33% | ||
| -$177.51M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 13.32 | ||
| 13.32 | ||
| - | ||
| 4 | ||
| 96.68 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 3,253.83 | ||
| 5.29 | ||
| -24.42 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $493.40M | ||
| $404.30M | ||
| $531.40M | ||
| $409.44M | ||
| $38.00M | ||
| $30.73M | ||
| $1.39M | ||
| $367.00K | ||
| $9.73M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $164.37M | ||
| $179.54M | ||
| $428.00K | ||
| $0.00 | ||
| $428.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$129.06M | ||
| -$122.83M | ||
| $280.13M | ||
| $213.00K | ||
| -$129.27M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Truist Securities | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| Evercore ISI Group | → | |
| Wedbush | → | |
| Wolfe Research | ||
| Wells Fargo | ||
| Wedbush | → | |
| Wedbush | → | |
| Raymond James | → |
Analyst sentiment
Institutional ownership
No data
Screeners with DNTH
FAQ
- What is the ticker symbol for Dianthus Therapeutics, Inc.?
- The ticker symbol for Dianthus Therapeutics, Inc. is NASDAQ:DNTH
- Does Dianthus Therapeutics, Inc. pay dividends?
- No, Dianthus Therapeutics, Inc. does not pay dividends
- What sector is Dianthus Therapeutics, Inc. in?
- Dianthus Therapeutics, Inc. is in the Healthcare sector
- What industry is Dianthus Therapeutics, Inc. in?
- Dianthus Therapeutics, Inc. is in the Biotechnology industry
- What country is Dianthus Therapeutics, Inc. based in?
- Dianthus Therapeutics, Inc. is headquartered in United States
- When did Dianthus Therapeutics, Inc. go public?
- Dianthus Therapeutics, Inc. initial public offering (IPO) was on June 21, 2018
- Is Dianthus Therapeutics, Inc. in the S&P 500?
- No, Dianthus Therapeutics, Inc. is not included in the S&P 500 index
- Is Dianthus Therapeutics, Inc. in the NASDAQ 100?
- No, Dianthus Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Dianthus Therapeutics, Inc. in the Dow Jones?
- No, Dianthus Therapeutics, Inc. is not included in the Dow Jones index
- When was Dianthus Therapeutics, Inc. last earnings report?
- Dianthus Therapeutics, Inc.'s most recent earnings report was on August 4, 2026
- When does Dianthus Therapeutics, Inc. report earnings?
- The next expected earnings date for Dianthus Therapeutics, Inc. is November 5, 2026
Data Sources & References
- DNTH Official Website dianthustx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1690585/000169058526000006/0001690585-26-000006-index.htm
- DNTH Profile on Yahoo Finance finance.yahoo.com/quote/DNTH
- DNTH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dnth